Drug-drug interactions (DDIs) in subjects enrolling in clinical trials can impact not only safety of the patient but also study drug outcomes and data validity. This makes it critical to adequately screen and manage DDIs. | Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials